HawaiiSB 31952025–2026 Regular Session (Year 2)Senate

RELATING TO DRUGS FOR WEIGHT LOSS.

Sponsored By: Kurt Fevella (Republican)

In Committee

Summary

Requires the Department of Human Services to provide Medicaid and Medicare part D prescription drug program recipients with coverage of glucagon-like peptide-1 (GLP-1) drugs for weight loss. Appropriates funds.

DHSWeight LossObesityMedicareMedicaidGLP-1AppropriationHHS, WAM

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Kurt Fevella

    Republican • Senate

Cosponsors

  • Brenton Awa

    Republican • Senate

  • Stanley Chang

    Democratic • Senate

  • Rachele Lamosao

    Democratic • Senate

  • Angus L.K. McKelvey

    Democratic • Senate

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Referred to HHS, WAM.

    2/2/2026Senate
  2. Introduced.

    1/28/2026Senate
  3. Passed First Reading.

    1/28/2026Senate

Bill Text

Related Bills

Back to State Legislation